Expression of a pathogen-response program in peripheral blood cells defines a subgroup of Rheumatoid Arthritis patients

Genes and Immunity

Volumn 9, Issue 1, 2008, Pages 16-22

  van der Pouw Kraan, T C T M ^a   van Baarsen, L G M ^a   Wijbrandts, C A ^b   Voskuyl, A E ^a   Rustenburg, F ^a   Baggen, J M ^a   Dijkmans, B A C ^a   Tak, P P ^b   Verweij, C L ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; METHOTREXATE; PREDNISONE; TRANSCRIPTION FACTOR;

ADULT; ANTIBODY TITER; ARTICLE; BINDING SITE; BLOOD CELL; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN VERSUS ANIMAL COMPARISON; MACACA; MALE; NONHUMAN; POXVIRUS INFECTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; TRANSCRIPTION INITIATION; VIRUS RESISTANCE; VIRUS VIRULENCE;

ANIMALS; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENES, VIRAL; HOST-PARASITE INTERACTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; MACACA; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); SMALLPOX; TRANSCRIPTION FACTORS;

MACACA; POXVIRIDAE;

EID: 38549167507     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364438     Document Type: Article

References (42)

1. Takemura S, Braun A, Crowson C, Kurtin PJ, Cofield RH, O'Fallon WM et al. Lymphoid neogenesis in rheumatoid synovitis. J Immunol 2001; 167: 1072-1080.
2. Timmer TCG, Baltus B, Vondenhoff M, Huizinga TWJ, Tak PP, Verweij CL et al. Inflammation and ectopic lymphoid structures in Rheumatoid Arthritis synovial tissues dissected by genomics technology. Identification of the IL-7 signaling pathway in tissues with lymphoid neogenesis. Arthritis Rheum 2007; 56: 2492-2502.
3. Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with Concomitant Therapy Study Group. N Engl J Med 2000; 343: 1594-1602.
4. Kremer JM, Westhovens R, Leon M, Di Giorgio E, Alten R, Steinfeld S et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N. Engl J Med 2003; 349: 1907-1915.
5. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004; 350: 2572-2581.
6. Zendman AJ, van Venrooij WJ, Pruijn GJ. Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Rheumatology (Oxford) 2006; 45: 20-25.
7. Hueber W, Kidd BA, Tomooka BH, Lee BJ, Bruce B, Fries JF et al. Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum 2005; 52: 2645-2656.
8. Firestein GS, Zvaifler NJ. How important are T cells in chronic rheumatoid synovitis? II. T cell-independent mechanisms from beginning to end. Arthritis Rheum 2002; 46: 298-308.
9. Silman AJ, MacGregor AJ, Thomson W, Holligan S, Carthy D, Farhan A et al. Twin concordance rates for rheumatoid arthritis: Results from a nationwide study. Br J Rheumatol 1993; 32: 903-907.
10. Deighton CM, Wentzel J, Cavanagh G, Roberts DF, Walker DJ. Contribution of inherited factors to rheumatoid arthritis. Ann Rheum Dis 1992; 51: 182-185.
11. Ramirez AS, Rosas A, Hernandez-Beriain JA, Orengo JC, Saavedra P, de la FC et al. Relationship between rheumatoid arthritis and Mycoplasma pneumoniae: A case-control study. Rheumatology (Oxford) 2005; 44: 912-914.
12. Haier J, Nasralla M, Franco AR, Nicolson GL. Detection of mycoplasmal infections in blood of patients with rheumatoid arthritis. Rheumatology (Oxford) 1999; 38: 504-509.
13. Mehraein Y, Lennerz C, Ehlhardt S, Remberger K, Ojak A, Zang KD. Latent Epstein-Barr, virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization. Mod Pathol 2004; 17: 781-789.
14. Jenner RG, Young RA. Insights into host responses against pathogens from transcriptional profiling. Nat Rev Microbiol 2005; 3: 281-294.
15. van der Pouw Kraan TC, Wijbrandts CA, van Baarsen LG, Voskuyl AE, Rustenburg F, Baggen JM et al. Rheumatoid Arthritis subtypes identified by genomic profiling of peripheral blood cells: Assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis 2007; 66: 1008-1014.
16. Rubins KH, Hensley LE, Jahrling PB, Whitney AR, Geisbert TW, Huggins JW et al. The host response to smallpox: Analysis of the gene expression program in peripheral blood cells in a nonhuman primate model. Proc Natl Acad Sci USA 2004; 101: 15190-15195.
17. Demeter J, Beauheim C, Gollub J, Hernandez-Boussard T, Jin H, Maier D et al. The Stanford Microarray Database: Implementation of new analysis tools and open source release of software. Nucleic Acids Res 2007; 35: D766-D770.
18. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116-5121.
19. Loots GG, Ovcharenko I, Pachter L, Dubchak I, Rubin EM. rVista for comparative sequence-based discovery of functional transcription factor binding sites. Genome Res 2002; 12: 832-839.
20. Moynagh PN. TLR signalling and activation of IRFs: Revisiting old friends from the NF-kappaB pathway. Trends Immunol 2005; 26: 469-476.
21. Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K et al. Gene exprossion signature of fibroblast serum response predicts human cancer progression: Similarities between tumors and wounds. PLoS Biol 2004; 2: E7.
22. Wucherpfennig KW. Mechanisms for the induction of auto-immunity by infectious agents. J Clin Invest 2001; 108: 1097-1104.
23. Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 1999; 42: 2204-2212.
24. Stahl HD, Hubner B, Seidl B, Liebert UG, van dH I, Wilbrink B et al Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritis. Ann Rheum Dis 2000; 59: 342-346.
25. Balandraud N, Roudier J, Roudier C. Epstein-Barr virus and rheumatoid arthritis. Autoimmun Rev 2004; 3: 362-367.
26. Olsen N, Sokka T, Seehorn CL, Kraft B, Maas K, Moore J et al. A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells. Ann Rheum Dis 2004; 63: 1387-1392.
27. Hitchens MR, Robbins PD. The role of the transcription factor DP in apoptosis. Apoptosis 2003; 8: 461-468.
28. Lunardi C, Marguerie C, Walport MJ, So AK. T gamma delta cells and their subsets in blood and synovial fluid from patients with rheumatoid arthritis. Br J Rheumatol 1992; 31: 527-530.
29. Su AI, Pezacki JP, Wodicka L, Brideau AD, Supekova L, Thimme R et al Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci USA 2002; 99: 15669-15674.
30. Toussirot E, Wendling D, Tiberghien P, Luka J, Roudier J. Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein Gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis. Ann Rheum Dis 2000; 59: 533-538.
31. Par G, Rukavina D, Podack ER, Horanyi M, Szekeres-Bartho J, Hegedus G et al. Decrease in CD3-negative-CD8dim(+) and Vdelta2/Vgamma9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection. J Hepatol 2002; 37: 514-522.
32. Mihm S, Frese M, Meier V, Wietzke-Braun P, Scharf JG, Bartenschlager R et al. Interferon type I gene expression in chronic hepatitis C. Lab Invest 2004; 84: 1148-1159.
33. Lyles DS. Cytopathogenesis and inhibition of host gene expression by RNA viruses. Microbiol Mol Biol Rev 2000; 64: 709-724.
34. Poccia F, Boullier S, Lecoeur H, Cochet M, Poquet Y, Colizzi V et al Peripheral V gamma 9/V delta 2 T cell deletion and anergy to nonpeptidic mycobacterial antigens in asymptomatic HIV-1-infected persons. J Immunol 1996; 157: 449-461.
35. Kasperkovitz PV, Timmer TC, Smeets TJ, Verbeet NL, Tak PP, van Baarsen LG et al. Fibroblast-like synoviocytes derived from patients witk rheumatoid arthritis show the imprint of synovial tissue heterogeneity: evidence of a link between an increased myofibroblast-like phenotype and high-inflammation synovitis. Arthritis Rheum 2005; 52: 430-441.
36. Kol A, Bourcier T, Lichtman AH, Libby P. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 1999; 103: 571-577.
37. Kawane K, Ohtani M, Miwa K, Kizawa T, Kanbara Y, Yoshioka Y et al. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 2006; 443: 998-1002.
38. Maas K, Chan S, Parker J, Slater A, Moore J, Olsen N et al. Cutting edge: Molecular portrait of human autoimmune disease. J Immunol 2002; 169: 5-9.
39. Anzilotti C, Merlini G, Pratesi F, Tommasi C, Chimenti D, Migliorini P. Antibodies to viral citrullinated peptide in rheumatoid arthritis. J Rheumatol 2006; 33: 647-651.
40. Nielsen TO, West RB, Linn SC, Alter Q, Knowling MA, O'Connell JX et al. Molecular characterisation of soft tissue tumours: A gene expression study. Lancet 2002; 359:1301-1307.
41. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863-14868.
42. Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vandergriff J, Rabkin S et al. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 2005; 33: D284-D288.